申请人:Epizyme, Inc.
公开号:US20150266854A1
公开(公告)日:2015-09-24
The present invention relates to substituted 6,5-fused bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof.
本发明涉及取代的6,5-融合的杂环芳基化合物。本发明还涉及含有这些化合物的制药组合物,并通过将这些化合物和制药组合物用于需要治疗癌症的受试者来治疗癌症的方法。